济民健康
(603222)
| 流通市值：33.13亿 | | | 总市值：33.13亿 |
| 流通股本：5.25亿 | | | 总股本：5.25亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 682,669,168.73 | 465,644,126.85 | 233,537,436.4 | 894,508,694.35 |
| 营业收入 | 682,669,168.73 | 465,644,126.85 | 233,537,436.4 | 894,508,694.35 |
| 二、营业总成本 | 651,011,799.9 | 435,482,905.65 | 217,016,663.75 | 867,978,348.65 |
| 营业成本 | 387,422,947.74 | 259,049,329.69 | 131,185,344.74 | 514,957,500.2 |
| 税金及附加 | 8,942,338.07 | 5,915,979.14 | 2,848,145.58 | 11,594,446.23 |
| 销售费用 | 124,930,077.38 | 83,334,932.72 | 41,643,363.33 | 184,330,111.09 |
| 管理费用 | 85,868,483.58 | 56,398,114.49 | 28,411,183.05 | 109,270,671.05 |
| 研发费用 | 30,296,180.81 | 21,826,968.73 | 8,023,873.53 | 28,900,349.86 |
| 财务费用 | 13,551,772.32 | 8,957,580.88 | 4,904,753.52 | 18,925,270.22 |
| 其中:利息费用 | 15,943,123.24 | 10,726,281.1 | 5,385,372.17 | 23,111,503.89 |
| 其中:利息收入 | 2,385,255.28 | 1,713,918.09 | 786,895.37 | 4,246,953.53 |
| 加:投资收益 | 1,243,236.52 | 660,572.36 | 661,832.68 | 4,127,872.78 |
| 资产处置收益 | 225,205.55 | - | - | -810,330.86 |
| 资产减值损失(新) | -1,385,080.11 | -1,338,177.06 | 104,273.95 | -23,077,022.23 |
| 信用减值损失(新) | -1,374,327.99 | 172,712.8 | 321,966.64 | -60,986,560.45 |
| 其他收益 | 7,372,165.76 | 5,150,228.04 | 3,472,370.02 | 10,386,800.8 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 37,738,568.56 | 34,806,557.34 | 21,081,215.94 | -43,828,894.26 |
| 加:营业外收入 | 90,301.12 | 20,099.12 | 2,400 | 319,515.56 |
| 减:营业外支出 | 2,985,295.69 | 1,989,201.31 | 1,177,112.45 | 5,648,155.69 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 34,843,573.99 | 32,837,455.15 | 19,906,503.49 | -49,157,534.39 |
| 减:所得税费用 | 1,440,398.33 | 1,788,646.39 | 1,394,842.38 | 41,608.86 |
| 六、净利润 | 33,403,175.66 | 31,048,808.76 | 18,511,661.11 | -49,199,143.25 |
| 持续经营净利润 | 33,403,175.66 | 31,048,808.76 | 18,511,661.11 | -49,199,143.25 |
| 归属于母公司股东的净利润 | 28,415,048.97 | 25,445,045.44 | 14,866,868.4 | -65,480,417.39 |
| 少数股东损益 | 4,988,126.69 | 5,603,763.32 | 3,644,792.71 | 16,281,274.14 |
| (一)基本每股收益 | 0.05 | 0.05 | 0.03 | -0.12 |
| (二)稀释每股收益 | 0.05 | 0.05 | 0.03 | -0.12 |
| 八、其他综合收益 | -372,317.12 | -1,962,096.21 | -1,825,960.27 | 4,642,095.72 |
| 归属于母公司股东的其他综合收益 | -372,317.12 | -1,962,096.21 | -1,825,960.27 | 4,642,095.72 |
| 九、综合收益总额 | 33,030,858.54 | 29,086,712.55 | 16,685,700.84 | -44,557,047.53 |
| 归属于母公司股东的综合收益总额 | 28,042,731.85 | 23,482,949.23 | 13,040,908.13 | -60,838,321.67 |
| 归属于少数股东的综合收益总额 | 4,988,126.69 | 5,603,763.32 | 3,644,792.71 | 16,281,274.14 |
| 公告日期 | 2024-10-30 | 2024-08-29 | 2024-04-26 | 2024-04-26 |
| 审计意见(境内) | | | | 标准无保留意见 |